Literature DB >> 12441930

Penile carcinoma. Is Nd:YAG laser therapy radical enough?

D Frimberger1, E Hungerhuber, D Zaak, R Waidelich, A Hofstetter, P Schneede.   

Abstract

PURPOSE: Penile carcinoma is a difficult disease to treat due to its aggressive nature and the psychological effects of amputation, which is often the recommended therapy. Outcome data from the last 13 years on patients with penile carcinoma treated with Nd:YAG laser coagulation were evaluated and compared with outcome data on conventional organ sparing techniques.
MATERIALS AND METHODS: For the last 13 years 29 patients were treated with Nd:YAG laser coagulation, including 17 with carcinoma in situ, and 10 with stage T1 and 2 with T2 cancer. Mean patient age was 55.1 years and mean followup was 46.7 months.
RESULTS: All patients are alive. Disease recurred in 1 patient with T1 tumor and 1 with carcinoma in situ. All patients were satisfied with the cosmetic and functional result.
CONCLUSIONS: Recurrence rates after Nd:YAG laser treatment for T1 tumors are comparable to those after partial amputation. Excellent cosmetic and functional results can be achieved without compromising oncological principles. For patients with metastasis prognosis is limited by the distant disease and, therefore, amputation is only necessary to achieve local control.

Entities:  

Mesh:

Year:  2002        PMID: 12441930     DOI: 10.1097/01.ju.0000036629.28231.85

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

Review 1.  [Systemic therapy of penile cancer].

Authors:  E Preis; P Albers; G Jakse
Journal:  Urologe A       Date:  2006-05       Impact factor: 0.639

Review 2.  [Options in palliative therapy for penile cancer].

Authors:  E Preis; G Jakse
Journal:  Urologe A       Date:  2007-01       Impact factor: 0.639

Review 3.  [Organ-sparing surgery for penile cancer].

Authors:  B Schlenker; C Gratzke; D Tilki; E Hungerhuber; P Schneede; O Reich; C G Stief; M Seitz
Journal:  Urologe A       Date:  2008-07       Impact factor: 0.639

Review 4.  Penile preserving and reconstructive surgery in the management of penile cancer.

Authors:  Arthur L Burnett
Journal:  Nat Rev Urol       Date:  2016-03-22       Impact factor: 14.432

Review 5.  Organ Preservation Surgery for Carcinoma Penis.

Authors:  T B Yuvaraja; Santosh Waigankar; Nikhil Dharmadhikari; Abhinav Pednekar
Journal:  Indian J Surg Oncol       Date:  2016-12-20

Review 6.  Organ-sparing procedures in GU cancer: part 2-organ-sparing procedures in testicular and penile tumors.

Authors:  Mohamed H Kamel; Mahmoud I Khalil; Ehab Eltahawy; Rodney Davis; Nabil K Bissada
Journal:  Int Urol Nephrol       Date:  2019-07-02       Impact factor: 2.370

7.  [Excision of carcinoma in situ of the glans penis with reconstructive plastic surgery].

Authors:  M Angerer-Shpilenya; N T Gaisa; G Jakse
Journal:  Urologe A       Date:  2010-03       Impact factor: 0.639

8.  Penile cancer: Clinical Practice Guidelines in Oncology.

Authors:  Peter E Clark; Philippe E Spiess; Neeraj Agarwal; Matthew C Biagioli; Mario A Eisenberger; Richard E Greenberg; Harry W Herr; Brant A Inman; Deborah A Kuban; Timothy M Kuzel; Subodh M Lele; Jeff Michalski; Lance Pagliaro; Sumanta K Pal; Anthony Patterson; Elizabeth R Plimack; Kamal S Pohar; Michael P Porter; Jerome P Richie; Wade J Sexton; William U Shipley; Eric J Small; Donald L Trump; Geoffrey Wile; Timothy G Wilson; Mary Dwyer; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2013-05-01       Impact factor: 11.908

9.  [Focal therapy for penile cancer].

Authors:  O W Hakenberg; C Protzel
Journal:  Urologe A       Date:  2016-05       Impact factor: 0.639

10.  Thulium-yttrium-aluminium-garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life.

Authors:  Gennaro Musi; Andrea Russo; Andrea Conti; Francesco A Mistretta; Ettore Di Trapani; Stefano Luzzago; Roberto Bianchi; Giuseppe Renne; Stefano Ramoni; Matteo Ferro; Deliu Victor Matei; Marco Cusini; Luca Carmignani; Ottavio de Cobelli
Journal:  World J Urol       Date:  2017-12-02       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.